Manifold Bio
Manifold Bio is positioned to be the leading tissue-specific medicines company.
$40M Series A ·
Source: startupintros.com
Total raised: $45M across 2 sourced rounds
All 2 rounds ↓Signals
About Manifold Bio
We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Manifold Bio | 710 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $40M | — | startupintros.com | |
| Seed | $5M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
GC
George Church Foundersource: manifold.bioGK
Gleb Kuznetsov Foundersource: manifold.bioPO
Pierce Ogden Foundersource: manifold.bioSL
Shane Lofgren Foundersource: manifold.bio
Companies like Manifold Bio
LLatus Bio$97M Series A · May 2026
NnChroma Bio$75M · Dec 2024
RReCode TherapeuticsSeries B+ · Oct 2023
MMindpeak$15.3M Series A · Oct 2024AAtrandi Biosciences$25M Series A · Feb 2025
BBiolincoPre Seed · Mar 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/manifold-bio (get a free API key).